The USC Iovine and Young Academy builds on convergent bioscience efforts with USC Dornsife’s Peter Kuhn to begin work on a new track for students aimed at helping patients participate in their own care.
Peter Kuhn of biological sciences travels to Vietnam, where he explains the university’s personalized approach to treatment and research at an international oncology conference.
The inaugural USC Hack for Health event brings together students from across disciplines to find new ways of turning technology against cancer.
Dean’s Professor of Biological Sciences Peter Kuhn believes that we need a continuum of care to support the continnuum of disease.
USC Michelson Center for Convergent Science emphasizes a collaborative approach to treating cancer patients.
The project aims to accelerate the development of reliable blood tests for biologically based precision treatment and disease monitoring.
University’s researchers participate in Vice President Joe Biden’s Cancer Moonshot exhibit.
USC joins White House summit on efforts that could accelerate research and improve patient outcomes.
With six high-profile papers published in the past seven months, biochemists in The Bridge@USC are poised to disrupt the future of pharmaceutical development and enable the advancement of personalized medicine.
Contact Ileana Wachtel
